Latest Articles
What's the Best Method for Endometrial Cancer Surveillance? - Cancer Nursing Today
What's the Best Method for Endometrial Cancer Surveillance? Cancer Nursing Today
Published: Sept. 26, 2025, 5:47 p.m.
KU Cancer Center Evaluating Progestin Use to Treat Endometrial Cancer | Newswise - Newswise
KU Cancer Center Evaluating Progestin Use to Treat Endometrial Cancer | Newswise Newswise
Published: Sept. 26, 2025, 1:45 p.m.
Woman’s stage 4 endometrial cancer treated successfully with combination therapy - MultiCare
Woman’s stage 4 endometrial cancer treated successfully with combination therapy MultiCare
Published: Sept. 26, 2025, 9:56 a.m.
Intuition to Influence: Casey’s Endometrial Cancer Journey - Yahoo News Canada
Intuition to Influence: Casey’s Endometrial Cancer Journey Yahoo News Canada
Published: Sept. 26, 2025, 5 a.m.
B.C. researchers lead AI breakthrough in endometrial cancer identification - CTV News
B.C. researchers lead AI breakthrough in endometrial cancer identification CTV News
Published: Sept. 26, 2025, 1:44 a.m.
Can AI Assist Patients With Endometrial Cancer Inquiries? - Cancer Nursing Today
Can AI Assist Patients With Endometrial Cancer Inquiries? Cancer Nursing Today
Published: Sept. 25, 2025, 9:34 p.m.
KU Cancer Center evaluating progestin use to treat endometrial cancer - University of Kansas Medical Center
KU Cancer Center evaluating progestin use to treat endometrial cancer University of Kansas Medical Center
Published: Sept. 25, 2025, 8:16 p.m.
CRT Boosts Survival in High-Risk Endometrial Cancer - Medscape
CRT Boosts Survival in High-Risk Endometrial Cancer Medscape
Published: Sept. 25, 2025, 10:18 a.m.
The Global Progesterone Test for Endometrial Cancer Market - openPR.com
The Global Progesterone Test for Endometrial Cancer Market openPR.com
Published: Sept. 25, 2025, 6:22 a.m.
Dostarlimab Plus Chemo Expands Frontline Options in Advanced/Recurrent Endometrial Cancer - OncLive
Dostarlimab Plus Chemo Expands Frontline Options in Advanced/Recurrent Endometrial Cancer OncLive
Published: Sept. 24, 2025, 7:04 p.m.
Link copied to clipboard!